Save 25% wITH TAKE25 at checkout.

Join the Defiants

Sign up to be the first to know about special offers and exciting Signos news.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
February 23, 2026
|
GLP-1
|
3 min read
|

Semaglutide for Weight Loss: Complete Beginner Guide

vial of medicine

While GLP-1 medications have been used to treat diabetes for years, they are quickly becoming one of the most talked-about weight loss medications, with semaglutide at the center of the conversation. With the massive level of attention semaglutide has received as an effective weight-loss treatment, misinformation and conflicting headlines and stories can make it difficult to know how it actually works or what you can really expect if you decide to use it. 

If you're just starting to research semaglutide, this guide will give you a clear understanding of what it is, how it works in the body, potential effects, and what you may want to discuss with your healthcare provider before starting treatment. 

What is Semaglutide? A Quick Overview

__wf_reserved_inherit

Semaglutide is one type of GLP-1 medication available on the market today. GLP-1s, or glucagon-like peptide-1 receptor agonists, stimulate insulin secretion, slow digestion and stomach emptying, and reduce appetite. While Ozempic and Rybelsus are approved to treat diabetes, another semaglutide, Wegovy, received approval in 2021 for weight loss. The other two semaglutide medications, Ozempic and Rybelsus, are sometimes prescribed off-label by physicians for weight loss, but are only approved for the treatment of type 2 diabetes. 

Wegovy is available as a once-a-week injectable medication or a once-daily pill. It alters how your body responds to the food you eat to induce weight loss, rather than a quick-fix diet or a supplement. It is typically prescribed to patients with obesity or who are overweight with at least one weight-related health condition, such as hypertension, type 2 diabetes, or dyslipidemia. 

In clinical trials, semaglutide has produced significant weight loss for people with obesity or who are overweight, when paired with lifestyle interventions. One study with almost 2,000 participants found that overweight or obese adults without diabetes lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% in the placebo group.

How Semaglutide Works in the Body

Semaglutide acts very similarly to the GLP-1 hormone naturally produced by the body. Semaglutide activates GLP-1 receptors found in the GI tract, pancreas, and brain to help reduce the amount of food you eat and activate metabolic responses that support weight loss and blood sugar regulation.2

  • Effects on glucose and insulin: The pancreas is stimulated to release more insulin to lower blood glucose levels and reduce the amount of glucose released by your liver. 
  • Slowed gastric emptying: Food moves more slowly through your digestive tract, so you feel full more quickly and for a longer period. 
  • Decreased appetite and food noise: As it works on the GLP-1 receptors in your brain, you may experience less food noise, reduced feelings of hunger, and higher feelings of satiety. 

The effects on your metabolism, feelings of fullness, and reduced hunger and food noise combine to effectively support weight loss. 

Blood Sugar and Metabolic Effects of Semaglutide

__wf_reserved_inherit

Semaglutide directly impacts how your body metabolizes glucose. First, it stimulates insulin release when your glucose levels rise after eating, then it suppresses glucagon, the hormone that signals your liver to release glucose into the bloodstream. These two effects combined lead to more stable blood glucose levels throughout the day. 

While this often results in improved A1C and fasting blood glucose levels, it also benefits overall glucose regulation and insulin sensitivity. Research shows that semaglutide improves glucose absorption and utilization by cells, reduces insulin resistance, and supports weight loss.3 By improving insulin sensitivity, semaglutide may help address some of the underlying metabolic factors that contribute to obesity and other metabolic diseases, not just the numbers. 

When starting semaglutide medications, changes in glucose metabolism may be the first effects you notice. Tools like a continuous glucose monitor (CGM) give you insights into these patterns as they occur, offering a glimpse of how your metabolism responds in the early stages of treatment. 

What to Expect When You First Start Using Semaglutide

Weight loss with semaglutide can take time, and doesn't happen at the same rate for everybody, but many people start to notice changes in weight within the first few months. In one study, patients receiving semaglutide injections titrated to 1 mg over 3 months achieved an average weight loss of 3.8% during the initial phase of treatment.4 To help your body acclimate to the medication, your physician will likely start you off at the lowest dose and gradually increase it as needed. 

Typical doses for Wegovy start at 0.25 mg (for the injectable) weekly for at least four weeks.2 Your healthcare provider may then suggest increasing incrementally as needed up to the maximum dose tolerated or warranted for positive effects, or until the maximum dose of 2.4 mg per week is reached. 

Side Effects and Tolerability Considerations

__wf_reserved_inherit

While semaglutide can help with weight loss and support metabolic changes that improve overall health, it can also come with several negative effects, both short-term and long-lasting. 

The most common short-term effects include gastrointestinal symptoms like nausea, diarrhea, constipation, cramping, and vomiting. For many, these effects are most problematic during dose increases, but diminish over time.  As delayed gastric emptying is one of the ways semaglutide supports weight loss, some people may experience gastroparesis, where this period extends even longer than it should, resulting in nausea, bloating, and uncomfortable feelings of fullness that last long after eating. 

Case reports of diabetic retinopathy, Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), acute pancreatitis, pulmonary aspiration, acute kidney injuries, and acute gall bladder injuries have been associated with the use of GLP-1s, but causation isn't established, as these cases are rare and may be influenced by other co-occurring factors.5 However, if you have any concerns, risk factors, or history of these or related conditions, you'll want to discuss these specific risks with your provider. 

Semaglutide also comes with a black box warning about the risk of thyroid C-cell tumors, including medullary thyroid carcinoma. It's essential to discuss your entire medical history and family medical history with your physician to weigh the risks vs benefits for this potential effect and others. 

Other risks include loss of lean muscle mass, bone loss, and nutritional deficiencies. However, these longer-term effects are less likely to appear in clinical trials, as participants receive appropriate nutritional and lifestyle guidance.6 But, even in some of the largest clinical trials, such as the STEP 1 trial, participants lost an average of 20 percent of their body weight from muscle tissue.7 Combining semaglutide treatment with nutritional counseling can help prevent or minimize these effects. 

Why Individual Results and Weight Loss Vary

__wf_reserved_inherit

One of the most common misconceptions about taking semaglutide for weight loss is that everyone will experience the same or even similar results. Extensive research has found that between 32 and 40 percent of people are "super responders" to semaglutide, losing 20 percent or more of their body weight, while 10 to 17 percent are non-responders, losing less than 5 percent of body weight.8

Several factors can influence how responsive you are to semaglutide treatment, including: 

  • Baseline metabolic health: People with existing insulin resistance or diabetes respond differently from those with fewer metabolic disruptions. One study found that people with type two diabetes may lose approximately 5 percent less body weight than those without diabetes while on semaglutide.8
  • Genetics: New research is identifying potential genetic markers that may determine how effectively an individual responds to semaglutide, suggesting your genetic makeup may play a larger role than once thought.9
  • Hormones: Thyroid, cortisol, and sex hormones all influence metabolism and how your body may respond to treatment. This is part of the reason women experience up to two times as much weight loss as men on average, and are more likely to be considered "super responders."8
  • Lifestyle: Diet, exercise, stress management, and sleep all play a large role in how successful this medication can be, as well as in reducing symptoms and side effects such as bone and muscle loss and malnutrition. 

The Role of Lifestyle During Semaglutide Use

__wf_reserved_inherit

Semaglutide is designed to be used alongside lifestyle changes, not instead of them. Among 33 randomized controlled trials with over 12,000 participants, those who paired lifestyle modifications with GLP-1 saw significant improvements in body composition and cardiometabolic markers, as well as significant weight loss.10

When starting semaglutide treatment, you may also consider focusing on these key areas: 

  • Nutrition: Understanding how to maximize your nutrition can help prevent nutrient deficiencies, muscle loss, and bone loss, and support your metabolism for the best results. Learn how to balance your meals with protein, fiber, and nutrient-rich plant foods as well as hydration strategies to feel your best. 
  • Exercise: Incorporating physical activity into your regular routine will support your metabolism, preserve muscle and bone mass, and boost your mood. 
  • Sleep and stress: Both of these factors are often overlooked, but play a large role in your metabolism, glucose regulation, and how you show up for yourself each day. 
  • Mental health: Seeking support from a mental health professional to work through any underlying obstacles you may have with food, body image, or self-esteem may help improve satisfaction, acceptance, and adherence to changes as you move through your journey. 

If you're struggling to make a diet and exercise routine stick or are unsure what to focus on for the best outcomes, consider working with a registered dietitian to help you create an effective plan and provide support on your journey. 

FAQs

1. What is semaglutide used for in weight loss?

Semaglutide is a GLP-1 receptor agonist. The brand name Wegovy is FDA-approved for weight loss for people with obesity or who are overweight with at least one weight-related health condition. It works by reducing appetite and food noise, slowing digestion, and improving glucose metabolism to support weight loss alongside lifestyle changes. 

2. How does semaglutide help with appetite control?

Semaglutide helps control appetite by mimicking the effects of the GLP-1 hormone on brain areas that regulate hunger and satiety, reducing appetite and helping you feel fuller faster. It also slows gastric emptying, which helps you feel fuller longer. 

3. Is semaglutide the same as Ozempic or Wegovy?

Wegovy and Ozempic both contain semaglutide as their active ingredient, but they're approved for different uses and prescribed at different doses. Wegovy is specifically approved for weight management, while Ozempic is approved for the management of type 2 diabetes. 

4. How long does it take to notice changes on semaglutide?

Most people begin to notice changes within the first few weeks, though significant weight changes are most often noted over the first three months and beyond as dosing increases. 

5. What are the common side effects beginners should know about?

The most frequently reported side effects are related to digestion, including nausea, diarrhea, cramping, and constipation. Slightly less common, some people experience vomiting as well. These symptoms tend to improve over time for many people and are more pronounced during periods of dose increases. If they do not improve or inhibit your ability to eat or drink, be sure to talk to your doctor. 

6. Is semaglutide meant to be a long-term medication?

Semaglutide is supported as a long-term treatment for chronic weight management, and not a short-term fix for weight loss. Research shows that after discontinuing semaglutide, most people regain at least two-thirds of the weight loss within the first year or two, which is why ongoing conversations with your healthcare provider about your treatment plan are important.11

Bottom Line

Taking semaglutide for weight loss can be an effective strategy to improve health markers and lose weight, but it is not a good fit for everyone. Understanding how the medication works, what the side effects and long-term effects may be, and realistic outcomes can provide you with the insights you need to have a productive conversation with your healthcare provider about your options. 

Learn More with Signos' Expert Advice

Whether you plan to take semaglutide for weight loss or want to better understand your metabolic health and how food and movement affect your glucose regulation and wellbeing, Signos can help. By gaining insights into how your meals, movement, and activities affect glucose levels, you can make strategic choices to move closer to your health goals.

Topics discussed in this article:

Kelsey Kunik, RDN

Kelsey Kunik, RDN

Kelsey Kunik is a registered dietitian, health and wellness writer, and nutrition consultant

Table Of Contents
Hands chopping zucchini and tomatoes on a colorful cutting board

Your body runs on glucose. Harness it with Signos.

As seen in:

SIGNOS INDICATIONS: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (Low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.